Calliditas Therapeutics Ab Annual Return on Equity ROE, Trends, Fundamental Ratios - CSIMarket
CSIMarket
 


Calliditas Therapeutics Ab  (NASDAQ: CALT)

CALT's ROE over the last five Years

Return on Equity, Annual Results, Trends, Rankings, Statistics


Return On Equity (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2018)
2020

Y / Y Equity Change -54.72 % -33.98 % -27.19 % - -
Y / Y Net Income Change - - - - -
Return On Equity - - - - -


You need to upgrade your Flash Player


Financial Statements
Calliditas Therapeutics Ab's Equity $ 33 Millions Annual CALT's Balance sheet
Calliditas Therapeutics Ab's Annual Income $ -44 Millions Annual CALT's Income Statement
Where are CALT's Income coming from? Visit CALT's Income by Segment





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.